All In Biotech

Drug Trial Radar · NCT00398931

FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)

A 5-year, Double-blind, Randomized, Placebo-controlled Extension Study to Examine the Long-term Safety and Efficacy of Oral Alendronate in Postmenopausal Women Who Previously Received Alendronate in Conjunction With the Fracture Intervention Trial

Last checked: Nov 20, 2026Latest source record: Feb 3, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,099 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,099

Actual

Start

Feb 1998

Primary completion

Oct 2003

Study completion Oct 2003

Sponsor

Lead sponsor
Organon and CoIndustry
Sponsor type
Industry
First posted
Nov 14, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
Female only, from 60 years, up to 86 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study was conducted among women who had previously received alendronate for 3 to 6 years during the Fracture Intervention Trial (FIT). Participants in the FLEX study were randomly assigned to receive alendronate (either 5 or 10 mg/day) or matching placebo during the next 5 years, in order to evaluate the effects of continuing or discontinuing alendronate treatment on bone mineral density and biochemical markers of bone turnover.

Conditions

  • Osteoporosis, Postmenopausal

Interventions

  • MK0217, alendronate sodium / Duration of Treatment : 5 YearsDrug

  • Comparator : placebo (unspecified) /Duration of Treatment : 5 YearsDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total hip bone mineral density (BMD)

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.